Skip to main content
TipRanks
Go Ultimate75% OFF

Alkyl Amines Chemicals Limited (ALKYLAMINE) AI Stock Analysis

3 Followers
IN:ALKYLAMINE

Alkyl Amines Chemicals Limited

(NSE:ALKYLAMINE)

Select Model
Rating:70.6Outperform
Price Target:INR 1,751.00â–²(11.20% Upside)
Action:reiterated
Date:10/07/26

The overall score is driven mainly by the company’s strong financial resilience, with a robust, low-debt balance sheet and solid cash generation, balanced against recent margin compression and softer growth. The technical picture is constructive, with the price in an uptrend but momentum only moderately positive. A relatively demanding valuation, with a high P/E and modest dividend yield, tempers the attractiveness of the stock at current levels.

Positive Factors
Very low leverageMinimal debt gives Alkyl Amines substantial financial flexibility to fund operations, pursue capacity or product investments, and withstand weaker demand without excessive interest or refinancing pressure. This conservative balance sheet is a durable support for resilience over the next several quarters.
Negative Factors
Inconsistent revenue growthRevenue declines in two recent periods indicate that demand and volume growth have not been consistently sustained. Continued uneven top-line performance could limit operating leverage, make capacity planning less predictable, and delay a return to the stronger growth profile seen earlier.

Alkyl Amines Chemicals Limited (ALKYLAMINE) vs. iShares MSCI India ETF (INDA)

-30%-20%-10%0%10%20%30%IN:ALKYLAMINE-7.64%INDA-4.08%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 79.60B
Dividend Yield
0.64%
Average Volume (3M)
6,405
Price to Earnings (P/E)
32.5
Beta (1Y)
0.88
Revenue Growth
13.38%
EPS Growth
35.82%
Country
India
Employees
692
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

Alkyl Amines Chemicals Limited Business Overview & Revenue Model

Company Description

Alkyl Amines Chemicals Limited functions as a global producer and purveyor of a diverse portfolio of chemical substances, encompassing various amines, their derivatives, and a selection of specialized chemicals. The company's offerings include alipha...

Alkyl Amines Chemicals Limited Financial Statement Overview

Summary

Score reflects a very conservative, low-debt balance sheet and consistently positive operating cash flows, offset by compressed profit margins, softer revenue growth, and volatile free cash flow compared with prior years.

Income Statement

68Positive

Balance Sheet

83Very Positive

Cash Flow

72Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue14.06B15.36B15.72B14.41B16.83B15.42B
Gross Profit5.53B5.35B7.14B6.54B8.04B6.92B
EBITDA3.20B3.16B2.98B2.55B3.49B3.27B
Net Income2.05B1.80B1.86B1.49B2.29B2.25B
Balance Sheet
Total Assets20.34B18.95B17.89B15.84B15.90B13.71B
Cash, Cash Equivalents and Short-Term Investments2.57B2.51B2.03B303.92M171.95M615.33M
Total Debt198.00M11.90M55.20M31.68M877.50M232.89M
Total Liabilities3.93B3.62B3.86B3.16B4.21B3.82B
Stockholders Equity16.42B15.33B14.02B12.67B11.69B9.90B
Cash Flow
Free Cash Flow01.10B2.15B1.53B-550.40M-422.81M
Operating Cash Flow02.39B2.63B2.75B2.48B2.05B
Investing Cash Flow0-1.37B-1.96B-1.21B-2.77B-2.06B
Financing Cash Flow0-560.90M-491.50M-1.40B80.00M-572.89M

Alkyl Amines Chemicals Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price1574.65

Price Trends

50DMA1755.42Negative
100DMA1826.17Negative
200DMA1686.49Negative

Market Momentum

MACD-49.87Negative
RSI37.25Neutral
STOCH40.31Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ALKYLAMINE, the sentiment is Negative. The current price of 1574.65 is below the 20-day moving average (MA) of 1619.44, below the 50-day MA of 1755.42, and below the 200-day MA of 1686.49, indicating a bearish trend. The MACD of -49.87 indicates Negative momentum. The RSI at 37.25 is Neutral, neither overbought nor oversold. The STOCH value of 40.31 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ALKYLAMINE.

Alkyl Amines Chemicals Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

IN:ALKYLAMINE against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:ALKYLAMINEIN:ALKYLAMINE71OutperformINR 80.54B32.52―0.64%13.38%35.82%
IN:VINATIORGAIN:VINATIORGA68NeutralINR 121.70B29.52―0.72%10.98%-5.48%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
IN:JUBLINGREAIN:JUBLINGREA61NeutralINR 91.41B25.83―0.87%15.41%21.76%
IN:BALAMINESIN:BALAMINES58NeutralINR 60.83B25.60―0.59%20.91%62.44%
IN:AARTIINDIN:AARTIIND47NeutralINR 165.88B28.02―0.22%39.85%103.71%
IN:LXCHEMIN:LXCHEM47NeutralINR 42.80B24.88―0.19%21.34%105.39%

* Basic Materials Sector Average

Performance Comparison

0%50%100%IN:ALKYLAMINEIN:AARTIINDIN:BALAMINESIN:JUBLINGREAIN:LXCHEMIN:VINATIORGADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:ALKYLAMINE and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:ALKYLAMINEAlkyl Amines Chemicals Limited1574.65-132.77-7.78%
IN:AARTIINDAARTI Industries Ltd457.3077.6620.45%
IN:BALAMINESBalaji Amines Limited1877.45761.3868.22%
IN:JUBLINGREAJubilant Ingrevia Ltd.573.90-129.61-18.42%
IN:LXCHEMLaxmi Organic Industries Ltd.154.00-29.99-16.30%
IN:VINATIORGAVinati Organics Limited1173.95-427.59-26.70%

Alkyl Amines Chemicals Limited Corporate Events

Alkyl Amines shareholders clear board restructuring and leadership extensions

Sep 21, 2026

Alkyl Amines Chemicals Limited has secured shareholder approval via postal ballot and remote e-voting for a suite of special resolutions that reshape its senior leadership structure. Key changes include the re-designation of Yogesh M. Kothari as Exec...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 07, 2026